Skip to content

Weizhen Xu, M.D.

NPI 1881787604ActiveIndividual· Pediatrics, Pediatric Endocrinology· New Brunswick, NJ

Pediatrics, Pediatric Endocrinology (M.D.) in New Brunswick, New Jersey, licensed in NJ and PA, with an NPI issued in October 2006. Part D covered 68 prescriptions written in 2024, 26% of them generic. Insulet Corporation was the largest of 2 companies reporting payments in 2025, $70.16 in all, mostly food and beverage.

Overview

NPI1881787604
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedOct 2, 2006
Last updated in NPPESFeb 23, 2012

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Pediatric Medicine (NJ)

Part D prescriptions in 2024

Prescriptions (claims)68 · 76 30-day fills
Total drug cost$17,951
Generic share26% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$70.16 · 3 payments from 2 companies
  • 2024$84.31 · 4 payments from 4 companies

Top paying companies in 2025

CompanyAmountPayments
Insulet Corporation$46.172
Novo Nordisk Inc$23.991

What the 2025 payments were for

  • Food and Beverage$70.16 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Endocrinology providers in New Brunswick

All Pediatrics, Pediatric Endocrinology providers in New Jersey